As an example, it's been demonstrated that prime-dose CsA—although not very low dose CsA—directly inhibits the expression of NFATc1 and IL-2 in human T cells from stimulated total blood samples, assessed by circulation cytometry (23). Hence, contrary to other cytotoxic immune suppressors, CsA will not get rid of the immune https://elizabethh555wjv9.hazeronwiki.com/user